GO
Loading...

Bristol-Myers Executive Charged With Insider Trading

FBI agents arrested Robert Ramnarine, a Bristol-Myers Squibbexecutive, on Thursday. He has been criminally charged with insider trading the call options of companies shortly before they were acquired, court papers show.

CNBC.com

Ramnarine, an assistant director for capital markets in Bristol-Myers' office in Princeton, N.J., was arrested by agents at a suburban New Jersey home this morning.

A three-count criminal complaint was unsealed this morning. According the complaint, he made more than $311,000 in illegal profit.

The insider trading in question involved several stocks, including ZymoGenetics, Pharmasset and Amylin Pharmaceuticals.

Ramnarine will have his initial court appearance later this afternoon. It is unclear whether Ramnarine has hired a lawyer for his defense.

In his position at Bristol-Myers Squibb, he was responsible for conducting due diligence concerning the pension plans of the company's acquisition targets.

No immediate response from Bristol-Myers Squibb was available.

— By CNBC's Jim Forkin. Reuters contributed to this article.

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More

Don't Miss

U.S. Video

  • Mad Money's Jim Cramer breaks down the theme of stealth technology stocks. Cramer says companies that are using proprietary technology to invent entirely new markets and then dominate those markets, fall under that category.

  • Mad Money host Jim Cramer knows it can be difficult to stick with a stock that is going lower but says if you've done the homework, and the story isn't wildly off the rails, then stay long.

  • Mad Money host Jim Cramer, outlines the most common emotionally driven investor mistakes and expresses why it is important to not let skepticism run away with you.